Prof. Dr. Barbara Lawrenz, PhD

Scientific Director, ART Fertility Clinics Guest professor, Reproductive Unit UZ Gent, Belgium Specialist Reproductive Medicine and Infertility

Scientific Director, ART Fertility Clinics

Prof. Barbara Lawrenz obtained her Medical Degree from Germany and completed her specialization in Gynecology and Obstetrics, she also gained expertise in Obstetrics and Prenatal Medicine followed by Gynecological Endocrinology and Reproductive Medicine. Prof. Lawrenz is an expert in fertility preservation before cytotoxic therapy in women with malignant diseases and fertility preservation for those undergoing cancer treatment and cancer survivors and she has a PhD in this topic. She has authored/co-authored 97 pub-med reviewed articles in international journals and additional articles in various prestigious German journals. Her main research focus is on the luteal phase support and treatment individualization. Prof. Lawrenz was the Head of the IVF Department at Women’s University Hospital Tubingen, Germany, and is an esteemed member of the European Society of Human Reproduction (ESHRE). Furthermore, she is a guest professor at the Reproductive Unit of UZ Gent in Belgium.

English and German

Abu Dhabi

Book Now

Experience

IVF Specialist, Abu Dhabi, UAE
Head of IVF department, Women´s University Hospital Tübingen, Germany
Senior Physician in Gynecology and Obstetrics, Women´s University Hospital Tübingen, Germany
Senior Physician in Gynecology and Obstetrics, General Hospital of Sindelfingen, Germany
Senior Physician in Gynecology and Obstetrics, General Hospital of Speyer, Germany
Residency in Gynecology and Obstetrics, General Hospital of Reutlingen, Germany

Educational Qualification

Global Clinical Scholars Research Training (GCSRT) Certificate Program, Harvard Medical School. Boston, USA, 2020-2021.
Habilitation thesis: Fertility preservation before cytotoxic therapy in young girls, adolescents, and premenopausal women. Obtaining the designation lecturer (“Privatdozentin”) Teaching license of the University of Tübingen for Obstetrics and Gynecology
Certificate for University Teaching and Learning in Medicine
Specialization in gynecological endocrinology and reproductive medicine
Specialization in obstetrics and perinatal medicine
Specialist in gynecology and obstetrics
Doctoral dissertation: “Determination of Protein C with capillary methods” Grade: “cum laude”
Study of medicine in Berlin and Giessen, Germany

Publications

Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay
Inter-assay variation and reproducibility of progesterone measurements during ovarian stimulation for IVF
The effects of cancer therapy on women’s fertility: what do we know now?
Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing
Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population?
Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation – a retrospective analysis of the Ensure data
Luteal phase serum progesterone levels after GnRH-agonist trigger – how low is still high enough for an ongoing pregnancy?
Premature progesterone elevation: targets and rescue strategies
Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes
Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
Premature progesterone rise in ART-cycles
What Drives Embryo Development? Chromosomal Normality or Mitochondria?
Individual luteolysis pattern after GnRH agonist trigger for final oocyte maturation
Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity
Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols
Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles
Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and “freeze all policy” without luteal phase support: a report of four cases
A non -receptive ERA test result in an HRT cycle may not be replicable in a natural cycle: A case report
Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist
Reply: Careful and expert interpretation of PGT-A data can resolve the mosaicism dilemma
Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
The importance of embryo quality and day of biopsy in frozen single euploid blastocyst transfer cycles
Anti-Müllerian Hormone as a Quantitative and Qualitative Marker of Euploid Blastocysts.
ESHRE 2019: The Depth of Embryo Replacement Inside the Uterine Cavity Influences Pregnancy and Implantation Rates in IVF
Is There A Relationship Between Mitochondrial DNA Content And Abortion Rate In Patients Undergoing Single Euploid Frozen Embryo Transfer ?
Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study.
IS PARENTAL CONSANGUINITY ASSOCIATED WITH LOW OVARIAN RESERVE AND HIGHER RATE OF ANEUPLOIDIES?
Mitochondrial DNA content of cleavage stage embryos and their relation to preimplantation development and aneuploidy
Cleavage stage mitochondrial DNA is correlated with preimplantation human embryo development and ploidy status
mtDNA dynamics between cleavage-stage embryos and blastocysts
The clinicians ́ dilemma with mosaicism—an insight from inner cell mass biopsies
Anti-Müllerian Hormone (AMH) as a quantitative and qualitative marker of euploid blastocysts.
Anti-Müllerian Hormone (AMH) is an independent marker for oocyte survival post vitrification.
Individualized luteal phase support
A non -receptive ERA test result in an HRT cycle may notbe replicable in a natural cycle: A case report
Ethnical and sociocultural differences causing infertility are poorly understood—insights from the Arabian perspective
Inhibin A—A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI
Is a naturally reduced antimullerian hormone at a young age linked to an increased risk of cancer development?
Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study
ANTI-MULLERIAN HORMONE IS AN INDEPENDENT MARKER FOR OOCYTE SURVIVAL POST-VITRIFICATION
The ART of frozen embryo transfer: back to nature!
The search must go on – for patients with recurrent pregnancy loss
Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A)
Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population Does blastocyst mitochondrial DNA content affect miscarriage rate in patients undergoing single euploid frozen embryo transfer?Gibt es optimale Serumprogesteronwerte in In-vitro-Fertilisations- und Kryozyklen?